Beware of These 2 Cannabis Stocks That Recently Missed Sales Estimates
StockNews
Published Nov 17, 2021 10:14AM ET
Updated Nov 17, 2021 11:30AM ET
Beware of These 2 Cannabis Stocks That Recently Missed Sales Estimates
Because the cannabis industry has been gaining steam with increasing legalization, more players are entering this space. And given the heightening competition, not all cannabis operators are well-positioned to capitalize on the industry tailwinds. So, we believe investors are better off avoiding cannabis stocks Curaleaf (CURLF) and Aurora Cannabis (NASDAQ:ACB), which missed their sales estimates recently. So, let’s examine these names.The cannabis industry is attracting significant investor attention on hopes surrounding a GOP-led effort to legalize marijuana at the federal level. However, the health risks associated with cannabis use in adolescents raise questions about marijuana consumption. Furthermore, the FDA has approved only four cannabis drug products to date. There is no cannabis-based animal or food product that the FDA has approved. Also, there are numerous hemp-derived CBD products on the market that are not approved by the FDA for human or veterinary use.
Several challenges, including restricted access to capital and a federal criminal statute surrounding cannabis' production and distribution, could impede the industry’s growth. On the other hand, with cannabis industry laws becoming gradually more accommodating, more players are entering this space, making the industry highly competitive. So, not all cannabis operators are well-positioned to withstand the challenges and survive in a heavily competitive market.
Given this backdrop, we think it could be wise to avoid fundamentally weak cannabis stocks Curaleaf Holdings, Inc. (OTC:CURLF) and Aurora Cannabis Inc. (ACB). These companies have also missed sales estimates in their recently released results.
Continue reading on StockNews
Get The News You Want
Written By: StockNews
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.